🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 097702104
- Market Cap
- Large Cap · $1 Billion
- IPO
- 2/5/2021 · $20.00/share
Business: Bolt Biotherapeutics is a clinical-stage immuno-oncology company developing tumor-targeted therapies that leverage the power of the innate and adaptive immune systems. Bolt’s proprietary Boltbody™ Immune-stimulating Antibody Conjugate (ISAC) approach uses immunostimulants to engage and activate myeloid cells that directly kill tumor cells.
Company Contact
- CEO
- Randall C. Schatzman
- CFO
- William P. Quinn
- Headquarters
- 900 Chesapeake Drive, Redwood City, CA 94063
- Phone
- 650-665-9295
- Investor Relations
- Karen L. Bergman · 650-665-9295 · kbergman@boltbio.com